Disc Medicine (IRON) Invested Capital (2020 - 2026)

Disc Medicine (IRON) has reported Invested Capital for 6 consecutive years, with $60.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Invested Capital rose 100.0% year-over-year to $60.0 million; the TTM figure through Jun 2026 stood at $150.0 million (up 66.67% YoY), while the FY2025 annual figure was $30.0 million, changed 0.0% from the prior year.
• Invested Capital rose to $60.0 million in Q2 2026 per IRON's latest filing, from $30.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $60.0 million in Q2 2026 and bottomed at $2.9 million in Q2 2022.
• Historically, Invested Capital has averaged $27.5 million across 4 years, with a median of $30.0 million in 2024.
• Annual changes were most pronounced in 2022 — Invested Capital slumped 41.74% — and 2026, when it jumped 100.0%.
• Disc Medicine's Invested Capital stood at $2.9 million in 2022, then jumped by 929.87% to $30.0 million in 2024, then changed by 0.0% to $30.0 million in 2025, then surged by 100.0% to $60.0 million in 2026.
• Business Quant data shows IRON's Invested Capital at $60.0 million in Q2 2026, $30.0 million in Q1 2026, and $30.0 million in Q4 2025.